Surveillance of antibiotic resistance in clinical isolates of streptococcus pneumoniae collected in Belgium during winter 2000-2001

被引:0
|
作者
Vanhoof, R
Carpentier, M
Cartuyvels, R
Damée, S
Fagnart, O
Garrino, MG
Glupczynski, Y
Gordts, B
Govaerts, D
Magerman, K
Mans, I
Surmont, I
Van Bossuyt, E
Van De Vyvere, M
Van Landuyt, H
Van Nimmen, L
Van Noyen, R
机构
[1] Pasteurinst Brussel, Eenheid Antibiot Onderzoek, B-1180 Brussels, Belgium
[2] Hop Citadelle, Microbiol Lab, B-4000 Liege, Belgium
[3] Clin St Etienne, Lab Van Den Abbeele, B-1210 Brussels, Belgium
[4] Clin Univ Mt Godinne, Microbiol Lab, B-5530 Yvoir, Belgium
[5] ZA St Jan, Microbiol Lab, B-8000 Brugge, Belgium
[6] CHU Andre Vesale, Microbiol Lab, B-6110 Montignies Le Tilleul, Belgium
[7] Virga Jesseziekenhuis, Microbiol Lab, B-3500 Hasselt, Belgium
[8] H Hartziekenhuis, Microbiol Lab, B-8800 Roeselare, Belgium
[9] AZ Stuivenberg, Microbiol Lab, B-2060 Antwerp, Belgium
[10] AZ Jan Palfijn, Microbiol Lab, B-9000 Ghent, Belgium
[11] Imeldaziekenhuis, Microbiol Lab, B-2820 Bonheiden, Belgium
来源
ACTA CLINICA BELGICA | 2003年 / 58卷 / 02期
关键词
S; pneumoniae; resistance; surveillance;
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
A total of 314 isolates of Streptococcus pneumoniae collected by 10 different laboratories were tested for their susceptibility by using a microdilution technique following NCCLS recommendations. The following antibiotics were included: penicillin, ampicillin, amoxicillin, amoxicillin/clavulanate, cefaclor, cefuroxime, cefotaxime, imipenem, ciprofloxacin, gemifloxacin, levofloxacin, erythromycin, clarithromycin, azithromycin, miocamycin, clindamycin and tetracycline. The insusceptibility rate (IR) to penicillin was 21.0% [10.8% intermediate (greater than or equal to0.12-1 mug/mL) and 10.2 % high-level (greater than or equal to2 mug/mL)], to cefotaxime 7.3 % [3.5 % intermediate (greater than or equal to 1 mug/mL) and 3.8 % high-level (greater than or equal to2 mug/mL)], to imipenem 3.8 % [3.8 % intermediate (greater than or equal to0.25-0.5 mug/mL) and 0 % high-level (greater than or equal to1 mug/mL)], to ciprofloxacin 11.2 % [8.3 % intermediate (2 mug/mL) and 3.9 % high-level (greater than or equal to4 mug/mL)], to erythromycin 30.3 % [3.5 % intermediate (0.5 mug/mL) and 26.8 % high-level (greater than or equal to1 mug/mL)] and to tetracycline 38.5 % [0.9 % intermediate (4 mug/mL) and 37.6 % high-level (greater than or equal to8 mug/mL)]. No decreased susceptibility was found for gemifloxacin (greater than or equal to0.5 mug/mL). This compound was the most active with MIC50, MIC90 and an IR of 0.015 mug/mL, 0.03 mug/mL, and 0 % respectively, followed by amoxicillin/ clavulanate, amoxicillin and imipenem (MIC50, MIC90 and IR: 0.015 mug/mL, 1 mug/mL, 1.6 %/ 0.015 mug/mL, 1 mug/mL, 1.9 %/ 0.008 mug/mL, 0.12 mug/mL, 3.8 % respectively). Compared to the 1999 surveillance, penicillin and tetracycline-insusceptibility increased with 4.9 % and 15.6% respectively, while cefotaxime, erythromycin and ciprofloxacin insusceptibility decreased with 5.4 %, 5.8 % and 4.4 % respectively. MICs of all beta-lactams rose with those of penicillin for penicillin-insusceptible isolates. Imipenem, cefotaxime, amoxicillin and amoxicillin/clavulanate were generally 4, 2, 1 and 1 doubling dilutions respectively more potent than penicillin on these isolates while ampicillin, cefuroxime and cefaclor were generally 1, 2 and 4 dilutions respectively less potent. Most penicillin-insusceptible isolates remained fully susceptible to amoxicillin/clavulanate (92.4 %), amoxicillin (90.9 %) and imipenem (81.8 %). Erythromycin-tetracycline insusceptibility was the most common resistance phenotype (14.3 %). Three- and four-fold resistance was found in 12.4 % and 1.6 % respectively of the isolates. Most penicillin-insusceptible isolates were of capsular types 14 (22.7 %), 23 (21.2 %), 6 (18.2 %), 9 (13.6 %) and 19 (12.1 %).
引用
收藏
页码:111 / 119
页数:9
相关论文
共 50 条
  • [31] Antibiotic resistance genotype trend and association with host clinical characteristics in respiratoty isolates of streptococcus pneumoniae
    Hagiwara, Eri
    Suido, Yoshihiro
    Nakazawa, Atsuhito
    Sekine, Akimasa
    Kitamura, Hideya
    Baba, Tomohisa
    Shinohara, Takeshi
    Nishihira, Ryuichi
    Komatsu, Shigeru
    Kato, Terufumi
    Ogura, Takashi
    EUROPEAN RESPIRATORY JOURNAL, 2014, 44
  • [32] PHLS surveillance of antibiotic resistance, England and Wales: Emerging resistance in Streptococcus pneumoniae
    Speller, DCE
    Johnson, AP
    Cookson, BD
    Waight, P
    George, RC
    EMERGING INFECTIOUS DISEASES, 1996, 2 (01) : 57 - 58
  • [33] Mechanism of sulfonamide resistance in clinical isolates of Streptococcus pneumoniae (vol 41, pg 2121, 2000)
    Maskell, JP
    Sefton, AM
    Hall, LMC
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2000, 44 (05) : 1411 - 1411
  • [34] Antibiotic resistance of nasopharyngeal isolates of Streptococcus pneumoniae from children in Lesotho
    Mthwalo, M
    Wasas, A
    Huebner, R
    Koornhof, H
    Klugman, KP
    BULLETIN OF THE WORLD HEALTH ORGANIZATION, 1998, 76 (06) : 641 - 650
  • [35] Phenotypic and genotypic analysis of levofloxacin-resistant clinical isolates of Streptococcus pneumoniae collected in 13 countries during 1999-2000
    Critchley, IA
    Blosser-Middleton, RS
    Jones, ME
    Karlowsky, JA
    Karginova, EA
    Thornsberry, C
    Sahm, DF
    INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2002, 20 (02) : 100 - 107
  • [36] Antimicrobial resistance among invasive isolates of Streptococcus pneumoniae collected across Canada
    Davidson, Ross J.
    Melano, Roberto
    Forward, Kevin R.
    DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE, 2007, 59 (01) : 75 - 80
  • [37] Serotype distribution and antibiotic resistance of Streptococcus pneumoniae isolates collected from unvaccinated children with pneumonia at a province in central Vietnam
    Son, Bui Anh
    Hai, Tang Xuan
    Cuong, Tran Van
    Chinh, Duong Dinh
    Le, Thi-Hong-Hanh
    Dung, Nguyen Manh
    Dinh, Vu Nhat
    Anh, Do Ngoc
    IRANIAN JOURNAL OF MICROBIOLOGY, 2022, 14 (05) : 653 - 661
  • [38] Molecular surveillance of macrolide, tetracycline and quinolone resistance mechanisms in 1191 clinical European Streptococcus pneumoniae isolates
    Schmitz, FJ
    Perdikouli, M
    Beeck, A
    Verhoef, J
    Fluit, AC
    INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2001, 18 (05) : 433 - 436
  • [39] EXTREMELY HIGH-INCIDENCE OF ANTIBIOTIC-RESISTANCE IN CLINICAL ISOLATES OF STREPTOCOCCUS-PNEUMONIAE IN HUNGARY
    MARTON, A
    GULYAS, M
    MUNOZ, R
    TOMASZ, A
    JOURNAL OF INFECTIOUS DISEASES, 1991, 163 (03): : 542 - 548
  • [40] Fluoroquinolone resistance among recent clinical isolates of Streptococcus pneumoniae
    Barry, AL
    Brown, SD
    Fuchs, PC
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1999, 43 (03) : 428 - 429